$SWBI

Smith and Wesson’s $160 million buy of Savage Arms makes it the largest commercial US firearms manufacturer

Smith & Wesson (SWBI) announced the acquisition of Savage Arms from JDH Holdings for $160 million. The deal aims to make Smith & Wesson the largest commercial U.S. firearms manufacturer, combining Savage's hunting expertise with Smith & Wesson's handgun and rifle markets. Savage, known for its hunting rifles, was founded in 1894 and has a long history in firearms manufacturing.

Original reporting
Published Oct 27, 2026, 5:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 5:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Smith and Wesson’s $160 million buy of Savage Arms makes it the largest commercial US firearms manufacturer — source image
Decision brief

The 30-second read

$SWBIBullishHigh
01

Why it matters

The acquisition is expected to broaden product offerings and improve scale, potentially boosting earnings.

02

Market read

A material M&A event for a mid‑cap listed company, likely to move the stock on the day of announcement.

03

What to watch

Financing terms of the deal and possible antitrust review are not disclosed.

Relevance 7/10Novelty 8/10Timing: today

Background

Smith & Wesson, a historic firearms maker, seeks to become the largest U.S. commercial firearms manufacturer through this acquisition.

Company-level read

Ticker impact

$SWBIBullishHigh confidence
Context

Smith & Wesson announced a $160 million acquisition of Savage Arms, expanding its firearms portfolio.

Expected impact

likely upward pressure as investors price in market‑share expansion

Evidence & confidence

Acquisition size is material for a mid‑cap and the combined product lines are complementary.

Market effects

Consolidation in the U.S. firearms sector may pressure peers' valuations.

U.S. firearms manufacturers could see increased investor interest.

Limited to domestic market; no immediate global ripple.

Counterpoint

Integration risks and potential regulatory scrutiny could weigh on the stock.

Key entities

  • Smith & Wesson

    U.S. firearms manufacturer, ticker SWBI

  • Savage Arms

    Private firearms maker acquired for $160 million

Related articles

$SWBIHigh

SMITH & WESSON BRANDS, INC. (SWBI): Completion of Acquisition or Disposition of Assets

SMITH & WESSON BRANDS, INC. (SWBI) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 Smith & Wesson Acquires Savage Arms • Creates leading U.S. firearms manufacturer, bringing together two iconic American brands • Meaningfully expands Smith & Wesson’s presence in hunting category • Expected to be immediately cash accretive to full year earnings per s

$SWBIHighAI 8/10

A firearms maker with more than 130 years of history now belongs to Smith & Wesson.

Smith & Wesson (SWBI) acquired Savage Arms, a 130-year-old firearms manufacturer, for $160M. The deal expands SWBI's hunting category presence and is expected to be immediately accretive to earnings per share by $0.04 for the remainder of fiscal 2027, with full-year accretion of $0.07 per share. JDH Capital, Savage's seller, becomes SWBI's largest stockholder with a 16.7% stake and board representation.

$SWBIMed

Smith & Wesson’s (SWBI) Profit Turnaround Comes With a Catch

Smith & Wesson (SWBI) reported a profit turnaround with Q2 net sales up 32.3% YoY to $112.6M and EPS of $0.06, reversing a prior loss. Shipments rose 20%, outpacing industry demand. Pricing power improved with ASPs up 9-18%. A $2.9M tariff refund boosted gross margin, but underlying gains were modest. The board approved a $0.13 quarterly dividend.

$SWBIHighAI 8/10

Smith & Wesson Brands, Inc. Q1 2027 Earnings Call Summary

Smith & Wesson Brands reported Q1 2027 net sales growth of 32%, driven by market share gains in handguns and long guns. The company maintained full-year revenue guidance of 5-7% and expects Q2 sales to rise 10% YoY. Gross margins expanded due to tariff refunds and production absorption, despite inflationary pressures. Capital spending is projected at $45M-$50M for the year, with Q2 operating expenses rising 10-15% sequentially.